Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen
Clinical trial NCT05037266 · TERMINATED
Trial details
- NCT number
- NCT05037266
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-20
- Primary completion
- 2022-02-14
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.